10x Genomics, Inc.(TXG)今日盘前大跌9.31%,引发市场关注。多家华尔街分析师调低了对该公司的评级和目标价格,成为推动股价下跌的重要因素。
根据路透社的报道,德意志银行将10x Genomics的目标价从25美元下调至16美元,花旗集团则将目标价从35美元下调至23美元。此外,摩根大通也将该股目标价从20美元下调至14美元,杰富瑞则从24美元下调至23美元。
分析师们普遍预期该公司的业绩将在未来一段时间内承受压力。部分报告称,当前宏观环境及行业前景不佳,可能会影响10x Genomics的销售增长和盈利水平。但分析师们并未详细解释下调目标价格的具体原因。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.